Cargando…
Oncogenic FGFR3 gene fusions in bladder cancer
FGF receptor 3 (FGFR3) is activated by mutation or over-expression in many bladder cancers. Here, we identify an additional mechanism of activation via chromosomal re-arrangement to generate constitutively activated fusion genes. FGFR3–transforming acid coiled coil 3 (TACC3) fusions resulting from 4...
Autores principales: | Williams, Sarah V., Hurst, Carolyn D., Knowles, Margaret A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554204/ https://www.ncbi.nlm.nih.gov/pubmed/23175443 http://dx.doi.org/10.1093/hmg/dds486 |
Ejemplares similares
-
ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer
por: di Martino, Erica, et al.
Publicado: (2019) -
FGFR3-TACC3 is an oncogenic fusion protein in respiratory
epithelium
por: Best, Sarah A., et al.
Publicado: (2018) -
Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer
por: Weickhardt, Andrew J., et al.
Publicado: (2022) -
Exploring the FGFR3-related oncogenic mechanism in bladder cancer using bioinformatics strategy
por: Cao, Wei, et al.
Publicado: (2017) -
Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer
por: Knowles, Margaret A., et al.
Publicado: (2009)